Delivery Order 75F40121D00021-75F40122F19011
Award Date 2/8/22
Potential Completion Date 6/8/22
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Biomerieux Inc. was awarded a $13,025.81 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Health and Human Services' Food and Drug Administration. The contract has no set-aside designation. Under the terms of the award, Biomerieux will provide consumable supplies to the FDA's laboratory in Calverton, Maryland, to support the agency's medical device testing and evaluation efforts through July 2026. Biomerieux is the prime contractor on...
- Biomerieux Inc. was awarded an $11,016 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration for Biomerieux consumables. The contract has no set-aside designation and deliveries are to be completed by December 6, 2026 at the agency's location in Calverton, Maryland. As the FDA is responsible for regulating food and medical products, this contract is likely to supply consumable materials used in the agency's laboratories for...
- Biomerieux Inc. has been awarded a delivery order under the FDA/NYHAFL Biomerieux Indefinite Delivery Indefinite Quantity (IDIQ) contract for three deliveries with a ceiling value of $44,605.92. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 3, 2026, and was awarded on March 23, 2026. The work will be performed at the FDA's location in Jamaica, New York. This delivery order represents a task-based procurement under an existing IDIQ...
- The Food and Drug Administration has awarded a delivery order valued at $21,662.16 to Biomerieux Inc. for three deliveries under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract. The award, made on April 6, 2026, is structured as a firm fixed-price delivery order with performance completion targeted for July 28, 2026. The work will be performed in Irvine, California. This delivery order represents a task order call against Biomerieux's established IDIQ contract vehicle with...
- The Food and Drug Administration awarded a $24,844.38 firm fixed-price delivery order to Biomerieux Inc. on April 13, 2026, with an ultimate completion date of August 20, 2026. This delivery order is issued under an existing FDA/Sanhafl Biomerieux Indefinite Delivery/Indefinite Quantity (IDIQ) contract and requires performance at Biomerieux's facility in Alameda, California. The award carries no set-aside designation, reflecting Biomerieux's status as a specialized sole-source provider of...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of its specialized clinical diagnostic equipment, reagents, and supplies. The $4,243.20 firm-fixed-price contract, awarded by the Food and Drug Administration (FDA), is a delivery order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of September 23, 2024 and does not involve any set-aside designation....
- Biomerieux Inc., operating as Vitek Systems, Inc., received a delivery order award from the Food and Drug Administration (FDA) for biomerieux consumables valued at $11,339.87 under a firm fixed-price contract. The order was placed on February 25, 2022, with an ultimate completion date of March 1, 2022, and will be performed at the company's facility in Calverton, Maryland. This award was issued without a set-aside designation, reflecting Biomerieux's specialized status as a provider of...
- Biomerieux Inc. was awarded a $31,995.61 firm fixed price delivery order against an unspecified contract vehicle to provide BIOMERIEUX VIDAS AND VITEK INSTRUMENTS for a single delivery to the Department of Health and Human Services Food and Drug Administration facility located in Eno Valley, North Carolina. The period of performance is through July 28, 2026 with no set-aside designation. As the leading provider of diagnostic solutions for use in clinical microbiology and infectious disease...
- This firm-fixed-price federal contract award was issued by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of its specialized consumables. The $1,386.10 contract has a completion date of December 1, 2021. Biomerieux Inc. is providing the FDA with its proprietary diagnostic platforms, reagents, and test kits, which are used for rapid pathogen detection and identification. This award is not associated with any set-aside...
- The U.S. Food and Drug Administration (FDA) awarded a $9,659.86 firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract, which is not set-aside, provides the FDA with various Biomerieux diagnostic products and consumables, including API 20 E strips, API Listeria, VIDAS Salmonella, VIDAS Listeria, VITEK 2 GN, and VITEK 2 GP. This contract is part of a larger Indefinite Delivery Vehicle (IDV) that...